Bio-Works Technologies AB (publ)

Stockholm Stock Exchange BIOWKS.ST

Bio-Works Technologies AB (publ) Goodwill for the year ending December 31, 2023

Bio-Works Technologies AB (publ) Goodwill is NA for the year ending December 31, 2023. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Stockholm Stock Exchange: BIOWKS.ST

Bio-Works Technologies AB (publ)

CEO	Ms. Lone Carlbom
IPO Date	Dec. 14, 2017
Location	Sweden
Headquarters	Virdings allé 18
Employees	35
Sector	Materials
Industries Plastics Biotechnology Chemicals & Advanced Materials Cleaning Supplies Containers & Packaging Personal Care Silver Vaccines

Description

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications. Bio-Works Technologies AB (publ) founded in 2006 and is headquartered in Uppsala, Sweden.

Key trends

Past 5 years